Table 3.
Changes to selected variables before and 3 months after treatment of hyperthyroidism with 131I.
| Before 131I | 3‐Month Re‐evaluation | P‐Value | |||
|---|---|---|---|---|---|
| Mean | SD | Mean | SD | ||
| T4 (nmol/L) | 112.7 | 49.3 | 23.2 | 11.7 | <.001 |
| M‐mode IVSd (mm) | 5.3 | 0.9 | 4.6 | 0.8 | .019 |
| M‐mode LVPWd (mm) | 6.0 | 1.6 | 5.1 | 1.2 | .001 |
| %FS | 56 | 9 | 50 | 9 | .006 |
| M‐mode LA:Ao | 1.4 | 0.2 | 1.3 | 0.2 | .51 |
| Median | Range | Median | Range | P‐Value | |
|---|---|---|---|---|---|
| NT‐proBNP (pmol/L) | 70 | 31–718 | 37.5 | <24–255 | .002 |
| cTNI (ng/mL) | 0.14 | 0.0–1.53 | 0.04 | 0.0–0.15 | .001 |
SD, standard deviation; IVSd, interventricular septal thickness during diastole; LVPWd, left ventricular caudal wall thickness during diastole; FS, fractional shortening; LA:Ao, ratio of left atrial to aortic diameter.